Kampei Shimizu

Kampei Shimizu

Auto-generated profile, based on publicly available information

Kampei Shimizu

Department of Neurosurgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2015 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
KSK. Shimizu
K. Shimizu
HIHirotoshi Imamura
Hirotoshi Imamura
YMYohei Mineharu
Yohei Mineharu
HAH. Adachi
H. Adachi
CSChiaki Sakai
Chiaki Sakai
NSN. Sakai
N. Sakai
BACKGROUND AND PURPOSE: Paraclinoid aneurysms have been increasingly treated endovascularly. The natural history of these aneurysms has gradually been elucidated. The purpose of this study was to assess the safety and efficacy of endovascular treatment for these aneurysms. MATERIALS AND METHODS: We performed a retrospective review of 377 patients with 400 paraclinoid aneurysms treated between January 2006 and December 2012. Their clinical records, endovascular reports, and radiologic and clinical outcomes were analyzed. Because aneurysms ≥7 mm are at higher risk of rupture, we classified aneurysms as small (<7 mm) or large (≥7 mm). RESULTS: Overall, 115 of the 400 aneurysms (28.8%) were large (≥7 mm). Thromboembolic complications were found significantly more often with large aneurysms than with small ones (7.4% vs 1.0%, P = .001). Hemorrhagic complications were found only with small aneurysms (0.7%). The 6-month morbidity rates were similar for small (1.0%) and large (0.8%) aneurysms. Immediate angiographic outcomes were similar (P = .37), whereas recurrences and retreatment occurred more frequently with large aneurysms (P = .001 and P = .007, respectively). Multivariate analysis showed that aneurysm size was the only independent predictor for recurrence (P = .005). Most recurrences (81%) were detected by scheduled angiography at 6 months. CONCLUSIONS: Aneurysm size influenced the type of complication (thromboembolic or hemorrhagic) and the recurrence rate. Given the approximately 1% annual rupture rate for aneurysms ≥7 mm, analysis of our data supports the rationale of using prophylactic endovascular treatment for unruptured paraclinoid aneurysms ≥7 mm.

12 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKampei Shimizu
Kampei Shimizu
HIHirotoshi Imamura
Hirotoshi Imamura
STShoichi Tani
Shoichi Tani
HAHidemitsu Adachi
Hidemitsu Adachi
CSChiaki Sakai
Chiaki Sakai
NSNobuyuki Sakai
Nobuyuki Sakai
Background and purpose: Establishment of drug therapy to prevent rupture of unruptured intracranial aneurysms (IAs) is needed. Previous human and animal studies have gradually clarified candidate drugs for preventive treatment of IA rupture. However, because most of these candidates belong to classes of drugs frequently co-administered to prevent cardiovascular diseases, epidemiological studies evaluating these drugs simultaneously should be performed. Furthermore, because drugs included in the same class may have different effects in terms of disease prevention, drug-by-drug assessments are important for planning intervention trials. Materials and methods: We performed a cross-sectional study enrolling patients diagnosed with IAs between July 2011 and June 2019 at our institution. Patients were divided into ruptured or unruptured groups. The drugs investigated were selected according to evidence suggested by either human or animal studies. Univariate and multivariate logistic regression analyses were performed to assess the association of drug treatment with rupture status. We also performed drug-by-drug assessments of the association, including dose-response relationships, with rupture status. Results: In total, 310 patients with ruptured and 887 patients with unruptured IAs were included. Multivariate analysis revealed an inverse association of statins (odds ratio (OR), 0.54; 95% confidence interval (CI) 0.38–0.77), calcium channel blockers (OR, 0.41; 95% CI 0.30–0.58), and angiotensin II receptor blockers (ARBs) (OR, 0.67; 95% CI 0.48–0.93) with ruptured IAs. Moreover, inverse dose-response relationships with rupture status were observed for pitavastatin and rosuvastatin among statins, benidipine, cilnidipine, and amlodipine among calcium channel blockers, and valsartan, azilsartan, candesartan, and olmesartan among ARBs. Only non-aspirin non-steroidal anti-inflammatory drugs were positively associated with ruptured IAs (OR, 3.24; 95% CI 1.71–6.13). Conclusions: The present analysis suggests that several types of statins, calcium channel blockers, and ARBs are candidate drugs for preventive treatment of unruptured IAs.

31 May 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MOMieko Oka
Mieko Oka
IOIsao Ono
Isao Ono
KSKampei Shimizu
Kampei Shimizu
MKMika Kushamae
Mika Kushamae
HMHaruka Miyata
Haruka Miyata
TATomohiro Aoki
Tomohiro Aoki
Considering the poor outcome of subarachnoid hemorrhage (SAH) due to the rupture of intracranial aneurysms (IA), mechanisms underlying the pathogenesis of IAs, especially the rupture of lesions, should be clarified. In the present study, a rat model of IAs in which induced lesions spontaneously ruptured resulting in SAH was used. In this model, the combination of the female sex and the bilateral ovariectomy increased the incidence of SAH, similar to epidemiological evidence in human cases. Importantly, unruptured IA lesions induced in female animals with bilateral ovariectomy were histopathologically similar to ruptured ones in the presence of vasa vasorum and the accumulation of abundant inflammatory cells, suggesting the exacerbation of the disease. The post-stenotic dilatation of the carotid artery was disturbed by the bilateral ovariectomy in female rats, which was restored by hormone replacement therapy. The in vivo study thus suggested the protective effect of estrogen from the ovary on endothelial cells loaded by wall shear stress. β-estradiol or dihydrotestosterone also suppressed the lipopolysaccharide-induced expression of pro-inflammatory genes in cultured macrophages and neutrophils. The results of the present study have thus provided new insights about the process regulating the progression of the disease.

1 March 2017 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
KSKampei Shimizu
Kampei Shimizu
HIHirotoshi Imamura
Hirotoshi Imamura
YMYohei Mineharu
Yohei Mineharu
HAHidemitsu Adachi
Hidemitsu Adachi
CSChiaki Sakai
Chiaki Sakai
NSNobuyuki Sakai
Nobuyuki Sakai

15 October 2022 in Translational Stroke Research
Verified
Journal Article
Closed access
PDF file
KSKampei Shimizu
Kampei Shimizu
TATomohiro Aoki
Tomohiro Aoki
NENima Etminan
Nima Etminan
KHKatharina A. M. Hackenberg
Katharina A. M. Hackenberg
STShoichi Tani
Shoichi Tani
NSNobuyuki Sakai
Nobuyuki Sakai

9 December 2022 in Surgical Neurology International
Verified
Journal Article
Open access
MMMasahiko Masahiko
Masahiko Masahiko
KSKampei Shimizu
Kampei Shimizu
STShoichi Tani
Shoichi Tani
MFMotoaki Fujimoto
Motoaki Fujimoto
HOHideki Ogata
Hideki Ogata
YAYoshinori Akiyama
Yoshinori Akiyama
Background: Nontraumatic true superficial temporal artery aneurysm (STAA) is rare, and its characteristics and pathogenesis are unclear.Methods: We report a case of STAA and performed a systematic review of PubMed, Scopus, and Web of Science using the keyword “superficial temporal artery aneurysm” to include studies on STAA reported through July 2022. We excluded studies on STAA associated with trauma, arterial dissection, infection, or vasculitis.Results: A 63-year-old woman who underwent left superficial temporal artery (STA)-middle cerebral artery bypass surgery 8 years previously was diagnosed with an aneurysm located at the left STA. The blood flow volume estimated by ultrasonography was higher in the left STA than in the contralateral counterpart (114 mL/min vs. 32 mL/min). She underwent clipping surgery to prevent aneurysmal rupture without sequela. The lesion was diagnosed as a true aneurysm by histology. The systematic review identified 63 cases (including the present case) of nontraumatic true STAA. The median age of the patients was 57 (interquartile range [IQR]: 41–70) years. Most (90.5%) cases were detected as a palpable mass. Aneurysmal rupture occurred in only 1 (1.6%) case, despite the large size of aneurysms (median size: 13 [IQR: 8–20] mm) and the high frequency (33.3%) of aneurysmal growth during observation. Most (93.7%) patients underwent surgical resection of STAA without sequela.Conclusion: Our findings suggest that the pathogenesis of true STAA is promoted by hemodynamic stress. The systematic review clarified patients’ and aneurysmal characteristics and treatment outcomes, providing further insight into the pathogenesis of nontraumatic true STAA.